2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
Neil J
NJ
Stone
Jennifer G
JG
Robinson
Alice H
AH
Lichtenstein
C Noel
CN
Bairey Merz
Conrad B
CB
Blum
Robert H
RH
Eckel
Anne C
AC
Goldberg
David
D
Gordon
Daniel
D
Levy
Donald M
DM
Lloyd-Jones
Patrick
P
McBride
J Sanford
JS
Schwartz
Susan T
ST
Shero
Sidney C
SC
Smith
Karol
K
Watson
Peter W F
PW
Wilson
D000328:Adult; D000572:American Heart Association / Q000458:organization & administration*; D002309:Cardiology / Q000458:organization & administration*; D008076:Cholesterol, HDL / Q000097:blood*; D008078:Cholesterol, LDL / Q000097:blood*; D003324:Coronary Artery Disease / Q000097:blood / Q000517:prevention & control*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006937:Hypercholesterolemia / Q000097:blood / Q000188:drug therapy*; D018570:Risk Assessment; D012307:Risk Factors; D040242:Risk Reduction Behavior; D012955:Societies, Medical; D014481:United States
D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors
ACC/AHA Practice Guideline; biomarkers, pharmacological; cardiovascular disease; cholesterol; diabetes mellitus; drug therapy; hydroxymethylglutaryl-CoA reductase inhibitors/statins; hypercholesterolemia; lipids; patient compliance; primary prevention; risk assessment; risk reduction behavior; secondary prevention